Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith Grehan

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Biorxiv : the Preprint Server for Biology|February 13, 2023
Production of antigenically stable enterovirus A71 virus-like particles in <i>Pichia pastoris</i> as a vaccine candidateNatalie J Kingston, Joseph S Snowden, Agnieszka Martyna, et al.
The Journal of General Virology|June 30, 2023
Production of antigenically stable enterovirus A71 virus-like particles in <i>Pichia pastoris</i> as a vaccine candidateNatalie J Kingston, Joseph S Snowden, Agnieszka Martyna, et al.
Vaccine|June 6, 2017
ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in miceNaif Khalaf Alharbi, Eriko Padron-Regalado, Craig P Thompson, et al.
NPJ Vaccines|May 29, 2026
Author Correction: Production of an immunogenic trivalent poliovirus virus-like particle vaccine candidate in yeast using controlled fermentationLee Sherry, Keith Grehan, Mohammad W Bahar, et al.
NPJ Vaccines|March 31, 2025
Production of an immunogenic trivalent poliovirus virus-like particle vaccine candidate in yeast using controlled fermentationLee Sherry, Keith Grehan, Mohammad W Bahar, et al.
Msphere|January 31, 2023
VelcroVax: a "Bolt-On" Vaccine Platform for Glycoprotein DisplayNatalie J Kingston, Keith Grehan, Joseph S Snowden, et al.
Nature Communications|January 18, 2025
Recombinant expression systems for production of stabilised virus-like particles as next-generation polio vaccinesLee Sherry, Mohammad W Bahar, Claudine Porta, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Biorxiv : the Preprint Server for Biology|February 13, 2023
Production of antigenically stable enterovirus A71 virus-like particles in <i>Pichia pastoris</i> as a vaccine candidateNatalie J Kingston, Joseph S Snowden, Agnieszka Martyna, et al.
The Journal of General Virology|June 30, 2023
Production of antigenically stable enterovirus A71 virus-like particles in <i>Pichia pastoris</i> as a vaccine candidateNatalie J Kingston, Joseph S Snowden, Agnieszka Martyna, et al.
Vaccine|June 6, 2017
ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in miceNaif Khalaf Alharbi, Eriko Padron-Regalado, Craig P Thompson, et al.
NPJ Vaccines|May 29, 2026
Author Correction: Production of an immunogenic trivalent poliovirus virus-like particle vaccine candidate in yeast using controlled fermentationLee Sherry, Keith Grehan, Mohammad W Bahar, et al.
NPJ Vaccines|March 31, 2025
Production of an immunogenic trivalent poliovirus virus-like particle vaccine candidate in yeast using controlled fermentationLee Sherry, Keith Grehan, Mohammad W Bahar, et al.
Msphere|January 31, 2023
VelcroVax: a "Bolt-On" Vaccine Platform for Glycoprotein DisplayNatalie J Kingston, Keith Grehan, Joseph S Snowden, et al.
Nature Communications|January 18, 2025
Recombinant expression systems for production of stabilised virus-like particles as next-generation polio vaccinesLee Sherry, Mohammad W Bahar, Claudine Porta, et al.
Pageof 2